Pharmacists in Edmonton, KY Accepting Medicare

6 Pharmacists found. Showing 1 - 6

Michael Granese, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 W Stockton St, Edmonton, KY 42129 Phone: 270-432-2725

Mr. Tony Ray Reynolds, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1704 West Stockton Street., Edmonton, Edmonton, KY 42129 Phone: 270-432-3111    Fax: 270-432-4111

Kevin Emberton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1704 W Stockton St, Edmonton, KY 42129 Phone: 270-432-3111

James B Murley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 W Stockton St, Edmonton, KY 42129 Phone: 270-432-2725

Mr. Casey Aaron Wade, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 W Stockton St, Edmonton, KY 42129 Phone: 270-432-2725

Kaytlyn Sharp, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 E Stockton St, Edmonton, KY 42129 Phone: 270-432-3051    Fax: 800-682-2091

News Archive

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Sartorius Stedim Biotech, a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration.

Innovative testing technology helps hospital save $3.7M

Kettering Medical Center has realized a positive financial impact of $3.7 million in the past year as the result of a change in standard operating procedures using a new innovative testing technology that diagnoses a wide variety of infectious diseases faster and more accurately than traditional testing.

UCSF scientists identify characteristics of progenitor cells

University of California San Francisco scientists have identified characteristics of a family of daughter cells, called MPPs, which are the first to arise from stem cells within bone marrow that generate the entire blood system. The researchers said the discovery raises the possibility that, by manipulating the fates of MPPs or parent stem cells, medical researchers could one day help overcome imbalances and deficiencies that can arise in the blood system due to aging or in patients with specific types of leukemia.

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

Read more Medical News

› Verified 5 days ago